Company / Working Capital
Ernexa Therapeutics Inc. Working Capital History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$20.0K
FY2025
5-year range
-$636.0K / $3.0M
FY2021-FY2025
Trend
+103.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 10 years, ranging from -$1M in FY2017 to $8M in FY2014.
Based on SEC 10-K filings.
$20,000 in FY2025 with a 10-year CAGR of -41.1%.
Declined from $3M to $20,000 over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -41.1%
Key checks
Key Insights
- In FY2025, working capital increased 103.4% year-over-year.
- Peak working capital was recorded in FY2014.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.0K | +103.4% |
| FY2024 | -$586.0K | -119.4% |
| FY2023 | $3.0M | +575.8% |
| FY2020 | -$636.0K | -2444.0% |
| FY2019 | -$25.0K | -100.9% |
| FY2018 | $2.8M | +349.0% |
| FY2017 | -$1.1M | -127.6% |
| FY2016 | $4.0M | +0.8% |
| FY2015 | $4.0M | -48.7% |
| FY2014 | $7.8M | +80.5% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026